Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

41.10

-2.64 (-6.04%)

At close: Feb 27, 2026, 4:00 PM EST

41.05

-0.05 (-0.12%)

After-hours: Feb 27, 2026, 7:04 PM EST

Crinetics Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	7.7	1.04	4.01	4.74	1.08
Revenue Growth (YoY)	640.71%	-74.11%	-15.28%	339.43%	1418.31%
Cost of Revenue	1.08	240.16	168.53	130.23	84.26
Gross Profit	6.62	-239.12	-164.51	-125.49	-83.18
Selling, General & Admin	191.33	99.74	58.09	42.39	24.53
Research & Development	332.06	-	-	-	-
Operating Expenses	523.39	99.74	58.09	42.39	24.53
Operating Income	-516.77	-338.85	-222.61	-167.88	-107.7
Interest & Investment Income	51.99	41.44	13.44	4.32	0.16
Earnings From Equity Investments	-	-0.47	-5.2	-1.01	-
Currency Exchange Gain (Loss)	-	-	-	-	-0.11
Other Non Operating Income (Expenses)	-0.36	-0.52	-0.16	0.66	0.01
Pretax Income	-465.14	-298.41	-214.53	-163.92	-107.64
Income Tax Expense	0.18	-	-	-	-
Net Income	-465.32	-298.41	-214.53	-163.92	-107.64
Net Income to Common	-465.32	-298.41	-214.53	-163.92	-107.64
Shares Outstanding (Basic)	94	81	58	52	38
Shares Outstanding (Diluted)	94	81	58	52	38
Shares Change (YoY)	16.43%	39.11%	11.71%	35.24%	26.24%
EPS (Basic)	-4.95	-3.69	-3.69	-3.15	-2.80
EPS (Diluted)	-4.95	-3.69	-3.69	-3.15	-2.80
Free Cash Flow	-383.68	-229.81	-171	-116.86	-89.02
Free Cash Flow Per Share	-4.08	-2.85	-2.94	-2.25	-2.32
Gross Margin	86.02%	-	-	-	-
Operating Margin	-6714.77%	-32613.47%	-5547.17%	-3544.06%	-9990.91%
Profit Margin	-6046.22%	-28720.69%	-5345.85%	-3460.38%	-9985.25%
Free Cash Flow Margin	-4985.50%	-22118.77%	-4261.03%	-2466.98%	-8258.26%
EBITDA	-512.88	-336.07	-221.51	-166.9	-106.78
D&A For EBITDA	3.89	2.79	1.1	0.98	0.92
EBIT	-516.77	-338.85	-222.61	-167.88	-107.7
Revenue as Reported	7.7	-	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q